טוען...
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
IMPORTANCE: Cardiac resynchronization therapy (CRT) reduces the risk for mortality and heart failure–related events in select patients. Little is known about the use of CRT in combination with an implantable cardioverter defibrillator (ICD) in patients who are eligible for this therapy in clinical p...
שמור ב:
| הוצא לאור ב: | JAMA Cardiol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Medical Association
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5814986/ https://ncbi.nlm.nih.gov/pubmed/28122073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2016.5388 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|